Over 3000 patients treated under Visiting Physicians Programme
The programme aims to provide exceptional healthcare services by partnering with leading global healthcare organisations, by attracting top medical professionals to Abu Dhabi.
The emirate has welcomed 37 visiting experts who have conducted 372 surgeries since the program was launched, as of December 2024.
The visiting physicians collaborated closely with local medical teams to exchange expertise, medical knowledge, and advanced techniques in complex medical fields.
Notably, in November 2024, Abu Dhabi completed its first selective dorsal rhizotomy surgery, performed by a highly-skilled visiting physician from the United States. These efforts highlight DoH's commitment to bringing world-class medical talents and best practices to Abu Dhabi to enhance healthcare services in line with global standards.
The Undersecretary of the DoH, Dr Noura Khamis Al Ghaithi, said: 'The DoH is committed to creating a holistic world-class healthcare ecosystem for Abu Dhabi residents and visitors so that patients can receive the medical attention they need, in line with global standards and best practices."
"The Visiting Physician Programme has played a key role in providing patients with a more convenient healthcare experience here in Abu Dhabi, especially in rare and complex medical cases. Through the programme, we are making the latest global medical innovations and expertise accessible to Abu Dhabi patients and reinforcing Abu Dhabi as a leading healthcare destination globally'.
The top five specialties seen by the visiting practitioners in 2024 include paediatric haematology (bone marrow transplant), plastic surgery (lymphedema and brachial plexus), adult orthopaedic surgeries (complex ankle, foot, shoulder, hand and scoliosis), paediatric orthopaedics (limb lengthening and limb deformities), and ophthalmology.
In addition to providing consultative services, the programme succeeded in enriching the exchange of knowledge, which significantly contributed to enhancing local expertise, post-surgical rehabilitation care, and improving healthcare outcomes throughout Abu Dhabi.
Visiting physicians have been brought from seven countries around the world, working with globally recognised healthcare organisations, to provide medical services in healthcare facilities across Abu Dhabi.
During 2024, 1,985 patients were seen by visiting practitioners and 270 surgeries were conducted.
Out of the 1,985 patients consulted, 94 per cent were successfully medically treated and were not required to travel abroad for treatment.
In 2024, four new specialties were added including retinoblastoma, selective dorsal rhizotomy, diabetic foot, and complex care clinic in recognition of the community requirements for these services. The complex care clinic initiative streamlines the evaluation and preliminary assessment of complex cases by the VPP expert in the US ahead of their visit to the emirate.
Visiting physicians involved in the programme are accessible to the public and appointments can be booked directly through the respective facilities.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The National
6 hours ago
- The National
Abu Dhabi hospital reveals new brain scan to detect Alzheimer's earlier
A scan that can detect Alzheimer's disease before memory loss begins is now available in the UAE for the first time. The amyloid PET scan, recently launched at Cleveland Clinic Abu Dhabi, is a milestone in the region's fight against neurodegenerative diseases and paves the way for treatment in patients as young as 40. The advanced diagnostic tool reveals the accumulation of amyloid plaque in the brain. These masses of protein collect on the brain and they are seen as indicators of looming Alzheimer's. Crucially, they appear long before symptoms become apparent, meaning treatment can be administered at an earlier stage, which in turn makes the treatment more effective. "Traditional imaging like MRI or CT scans cannot detect amyloid plaque," Dr Hanan Sheikh Ibrahim, staff physician at the hospital's Neurological Institute, told The National. "This scan, however, can reveal the core pathology and determine if the patient is amyloid-positive. That informs not only the diagnosis, but the treatment. "If the scan is positive, we know the patient is likely to benefit from the latest plaque-targeting drugs such as donanemab or lecanemab. If the scan is negative, we can rule out Alzheimer's and look for reversible causes – like vitamin deficiencies, thyroid issues, sleep disorders, or even seizures." Using the science The launch of the scan follows the roll-out of a blood-based biomarker test, announced earlier this year at Abu Dhabi Health Week, which can also predict whether a person is likely to develop Alzheimer's in the future. When combined, the two tools allow for precision diagnosis and offer patients the opportunity to begin treatment or lifestyle interventions early. The scan is used to diagnose mild cognitive impairment (MCI), an early stage of cognitive decline. It can also help distinguish Alzheimer's from other forms of dementia such as vascular dementia, frontotemporal dementia, or dementia with Lewy bodies – conditions that can sometimes have overlapping or misleading symptoms. Earlier is better 'Alzheimer's can begin 20 years before symptoms appear,' Dr Ibrahim said. 'If we see plaque in someone in their 40s, we can start modifying their risk factors like controlling diabetes, treating sleep apnoea, or improving vascular health. The goal is to delay or even prevent dementia.' This new approach is a stark contrast to previous decades, when a diagnosis of Alzheimer's was considered the equivalent of a death sentence. "In the past, disclosing Alzheimer's felt like telling someone they had metastatic cancer," Dr Ibrahim said. "There was no treatment. Now, with better understanding and better tools, we can manage it. Alzheimer's is becoming more like diabetes – incurable but modifiable. We can slow it down. "We've also pioneered blood-based biomarkers in the UAE, which we've been using for the past two years. A blood test alone can sometimes predict Alzheimer's up to a decade in advance. Combined with the scan, we can offer a much more accurate and earlier diagnosis.' Who should get checked? Dr Ibrahim encourages individuals as young as 40 and especially those with high risk factors, to undergo screening. 'If you're in your mid-40s and have conditions like diabetes, hypertension, obesity, sleep apnoea, or a history of head trauma, you should get assessed,' she said. 'Also, if you're noticing symptoms or if loved ones are noticing changes – those are red flags.' Common early signs include: Increased forgetfulness or repeating questions Trouble with multitasking or decision-making Changes in mood, personality, or behaviour Mismanaging finances or getting lost while driving Decline in cooking skills or personal hygiene 'If loved ones are concerned, you should be concerned,' she said. 'In fact, we have screening questionnaires we give to spouses or daughters, who are often the first to notice that something's not right.' Not all dementias are the same Dr Ibrahim also stressed the importance of differentiating between Alzheimer's and other types of dementia. 'Some forms, like frontotemporal dementia, cause severe behavioural issues, disinhibition, hallucinations, or personality changes. These can progress faster and are harder on families. Alzheimer's can be more manageable by comparison, especially when caught early. 'Vascular dementia, often caused by uncontrolled blood pressure or diabetes, can sometimes be reversed or slowed by managing those conditions. That's why getting the diagnosis right is essential. 'We've had patients who were thought to have dementia but actually had untreated seizures or sleep apnoea. Once those were treated, their cognition improved.' Setting a new standard Cleveland Clinic Abu Dhabi is now working with the Emirati Genome Project and other institutions to improve screening and research across the country. 'We are collaborating with other healthcare facilities to build a national dementia registry to better understand the landscape,' Dr Ibrahim said. 'Right now, I can't say whether we have more cases than other countries because my clinic is biased – I only see patients with memory issues. But we do have more risk factors such as diabetes, obesity, sleep disorders so we're certainly more vulnerable. 'With this technology, Abu Dhabi is setting a new standard for dementia care – not just regionally, but globally.'
Zawya
8 hours ago
- Zawya
Cleveland Clinic Abu Dhabi performs first robotic lung transplant in gulf region
Cleveland Clinic Abu Dhabi has made history by performing the Gulf region's first-ever robotic lung transplant, making it one of the five centres in the world to have performed this surgery. With this landmark complex surgery, two patients have now successfully undergone robotic lung transplants, marking a major milestone in the region's advanced surgical and organ transplant capabilities. Both patients had idiopathic pulmonary fibrosis (IPF) as well as secondary pulmonary hypertension, a progressive condition that gradually scars the lungs and makes breathing increasingly difficult. These surgeries were quite complex due to pulmonary hypertension, a condition that puts extra strain on the heart and lungs. To support the patients during the operation, the medical team used Veno-Arterial ECMO, a technique that temporarily takes over the work of the heart and lungs while the damaged lungs are replaced. These life-saving surgeries would not have been possible without the extraordinary generosity of organ donor families, whose selfless gifts make such transplants possible. The hospital also acknowledges the critical role played by healthcare professionals from donor hospitals, the National Programme for Organ Donation and Transplantation – HAYAT, the Department of Health- Abu Dhabi, and the National Centre at the Ministry of Health and Prevention (MOHAP). Further solidifying its leadership in regional transplant medicine, Cleveland Clinic Abu Dhabi has surpassed a significant milestone this year, completing over 60 lung transplants since the relaunch of the programme in 2022, establishing itself as the most advanced and active centre of its kind in the region. These cases exemplify the programme's potential and underscores Cleveland Clinic Abu Dhabi's emergence as a global referral hub for patients with end-stage lung disease, including complex conditions such as Chronic Obstructive Pulmonary Disease as well as Interstitial Lung Disease, Cystic Fibrosis, Pulmonary Hypertension, and Bronchiectasis.
Emirates 24/7
12 hours ago
- Emirates 24/7
UAEU scientists reveal how cells positively regulate metabolism via pathway crosstalk
A research team from the United Arab Emirates University (UAEU) has made a significant breakthrough in understanding how cells positively regulate their metabolism. The study offers new insight into the complex mechanisms that enable cells to adapt and respond to changing environmental conditions. The research was conducted under the supervision of Dr. Mohammad Tauqeer Alam, associate professor in the Department of Biology, College of Science, in collaboration with Prof. Markus Ralser from Charité – Universitätsmedizin Berlin, Germany, and Dr. Richard Notebaart from Wageningen University and Research, Netherlands. The study was published in the journal Molecular Systems Biology. Master's student Sultana Mohammed Al Zubaidi and PhD student Muhammad Ibtisam Nasar were the first co-authors of the study. Dr. Alam explained that the research provided a comprehensive network of intracellular enzyme–metabolite activator interactions by integrating the yeast metabolic network with enzyme data from multiple species. The findings revealed that most metabolic pathways include activatory interactions often linking across different pathways, highlighting extensive regulatory crosstalk within the cell's metabolic network. One key discovery is that the early steps in many metabolic pathways are positively regulated, effectively priming downstream reactions for more efficient execution. This enhances overall metabolic performance. The study also found that the most highly catalytic enzymes are often involved in secondary pathways, which are activated under specific environmental conditions. Meanwhile, macromolecules play an essential role in cell survival. Dr. Alam emphasised that these findings represent a major step forward in understanding how cells regulate internal processes. The insights open new avenues for research in metabolic engineering, biotechnology, and disease biology. Follow Emirates 24|7 on Google News.
